Pharmacological treatment of alcohol use disorder represents an essential core of the therapeutic project in a multidisciplinary approach. While non-drug treatment is evolving, from a medical perspective few pharmacotherapies are available; in particular acamprosate, naltrexone and more recently nalmefene among anticraving drugs, disulfiram as an antidipsotropic medication. New studies are focusing on off-label drugs. Moreover, scientific evidence has to support any therapeutic indication which should be tailored on patient needs and comorbidity by considering the individual bio-psycho-social profile. Follow-up is essential in order to assess patient compliance to treatment and monitoring outcomes.
Pharmacological treatment of alcohol use disorder. Scientific evidence / Perciballi, R.; Rotondo, C.; Capriglione, I.; Iannuzzi, S.; Attilia, M. L.; Vitali, M.; Scamporrino, MARIA CONCETTA MARCELLA; Fiore, M.; Ceccanti, M.; Addolorato, G.; Aliotta, V.; Barletta, G.; Battaglia, E.; Battagliese, G.; Carito, V.; Casciani, O.; Casella, P.; Cesarini, F.; Cibin, M.; Ciccarelli, R.; Ciolli, P.; Coriale, G.; Di Prinzio, A.; Fagetti, R.; Falconi, E.; Federico, M.; Ferraguti, G.; Fiorentino, D.; Gencarelli, S.; Giuliani, A.; Greco, A.; Intaschi, G.; Janiri, L.; Lagrutta, A.; La Torre, G.; Laviola, G.; Ledda, R.; Leggio, L.; Leonardi, C.; Loffreda, A.; Lugoboni, F.; Macri, S.; Mancinelli, R.; Marconi, M.; Maremmani, I.; Maviglia, M.; Messina, M. P.; Mistretta, M.; Montesano, F.; Parisi, M.; Pascale, E.; Pisciotta, F.; Spinnato, G.; Valchera, A.; Zavan, V.; Attilia, Fabio; Alessandrini, Giovanni. - In: RIVISTA DI PSICHIATRIA. - ISSN 0035-6484. - 53:3(2018), pp. 123-127. [10.1708/2925.29414]
Pharmacological treatment of alcohol use disorder. Scientific evidence
Perciballi R.Secondo
;Rotondo C.;Capriglione I.;Iannuzzi S.;Attilia M. L.;Vitali M.;SCAMPORRINO, MARIA CONCETTA MARCELLA;Ceccanti M.;Battagliese G.;Cesarini F.;Ciccarelli R.;Ciolli P.;Coriale G.;Ferraguti G.;Fiorentino D.;Gencarelli S.;Greco A.;La Torre G.;Ledda R.;Macri S.;Messina M. P.;Pascale E.;Pisciotta F.;Fabio AttiliaPrimo
;Giovanni Alessandrini
2018
Abstract
Pharmacological treatment of alcohol use disorder represents an essential core of the therapeutic project in a multidisciplinary approach. While non-drug treatment is evolving, from a medical perspective few pharmacotherapies are available; in particular acamprosate, naltrexone and more recently nalmefene among anticraving drugs, disulfiram as an antidipsotropic medication. New studies are focusing on off-label drugs. Moreover, scientific evidence has to support any therapeutic indication which should be tailored on patient needs and comorbidity by considering the individual bio-psycho-social profile. Follow-up is essential in order to assess patient compliance to treatment and monitoring outcomes.| File | Dimensione | Formato | |
|---|---|---|---|
|
Attilia_Pharmacological_2018.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
98.19 kB
Formato
Adobe PDF
|
98.19 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
